vimarsana.com

Page 3 - பாண்டியன் சிகிச்சை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Merck: the good value biotech stock that has cornered the cancer market

© Merck This year the technology-heavy Nasdaq Composite index has become increasingly volatile. The very high valuations of many large tech stocks offering no dividends have made investors nervous; they are also concerned that President Biden’s stimulus programme could increase inflation. Shares in electric-car maker Tesla, for example, fell by 36% between late January and early March.  A safer sector is healthcare, historically it’s one of the least volatile sectors. And within healthcare some of the large US biopharmaceutical stocks now offer reasonable valuations, worthwhile dividends and steady growth through new patented treatments for serious diseases.  One such stock is

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.